About
Genova Diagnostics operates a clinical laboratory that identifies root causes of chronic disease through advanced biomarker testing. The company has spent 40 years building integrated testing panels that connect patterns across body systems: gut health and immunity, metabolism and inflammation, nutrient status and hormonal function. Rather than viewing patients through isolated categories, Genova's approach recognizes that digestion influences immunity, that the microbiome affects hormones, and that these connections determine healthspan.
The company's core offerings include comprehensive stool analysis (GI Effects and Microbiomix), nutritional assessment (NutrEval), and specialized testing for methylation, genomics, oxidative stress, and emerging biomarkers like p-Tau217 for Alzheimer's detection. Microbiomix represents a functional layer beyond traditional sequencing, identifying gene-level potential for inflammation, detoxification disruption, and hormone interference. Genova operates a CLIA-certified laboratory and FDA-registered medical device manufacturing facility, ensuring clinical rigor alongside accessibility.
Genova's recent acquisition of Cell Science Systems expanded its immunology and cell biology testing capabilities, positioning the company to serve clinicians seeking a single lab partner that connects gastrointestinal health, immune function, nutrition, and metabolic drivers without sacrificing depth. The company serves practitioners and patients across over 50 countries, with dedicated support for North America, Europe, and international markets.
Longevity Contribution
- Integrated testing approach that connects multiple body systems (gut, immunity, metabolism, hormones) rather than treating them as isolated categories
- Proprietary Microbiomix technology that assesses microbial function at the gene level, identifying specific inflammatory and detoxification potential beyond standard sequencing
- Combination of multiple advanced methodologies (16S rRNA, shotgun sequencing, metabolite analysis) to capture complete gut health picture rather than relying on single methodology
- 40-year track record with CLIA certification and FDA-registered manufacturing facility, plus recent Cell Science Systems acquisition expanding immunology and cell biology testing depth